BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 30148909)

  • 1. [Atypical hemolytic uremic syndrome].
    Sepúlveda RA; Tagle R; Jara A
    Rev Med Chil; 2018 Jun; 146(6):770-779. PubMed ID: 30148909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment.
    Raina R; Krishnappa V; Blaha T; Kann T; Hein W; Burke L; Bagga A
    Ther Apher Dial; 2019 Feb; 23(1):4-21. PubMed ID: 30294946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical guides for atypical hemolytic uremic syndrome in Japan.
    Kato H; Nangaku M; Hataya H; Sawai T; Ashida A; Fujimaru R; Hidaka Y; Kaname S; Maruyama S; Yasuda T; Yoshida Y; Ito S; Hattori M; Miyakawa Y; Fujimura Y; Okada H; Kagami S;
    Clin Exp Nephrol; 2016 Aug; 20(4):536-543. PubMed ID: 27422619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atypical hemolytic uremic syndrome. Report of two cases treated with Eculizumab].
    Tagle R; Rivera G; Walbaum B; Sepúlveda RA
    Rev Med Chil; 2018 Feb; 146(2):254-259. PubMed ID: 29999163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atypical hemolytic uremic syndrome].
    Blasco Pelicano M; Rodríguez de Córdoba S; Campistol Plana JM
    Med Clin (Barc); 2015 Nov; 145(10):438-45. PubMed ID: 25433773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea.
    Cheong HI; Jo SK; Yoon SS; Cho H; Kim JS; Kim YO; Koo JR; Park Y; Park YS; Shin JI; Yoo KH; Oh D
    J Korean Med Sci; 2016 Oct; 31(10):1516-28. PubMed ID: 27550478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical Hemolytic Uremic Syndrome.
    Dixon BP; Gruppo RA
    Pediatr Clin North Am; 2018 Jun; 65(3):509-525. PubMed ID: 29803280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management.
    Sridharan M; Go RS; Willrich MAV
    J Immunol Methods; 2018 Oct; 461():15-22. PubMed ID: 30031798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.
    Rigothier C; Delmas Y; Roumenina LT; Contin-Bordes C; Lepreux S; Bridoux F; Goujon JM; Bachelet T; Touchard G; Frémeaux-Bacchi V; Combe C
    Am J Kidney Dis; 2015 Aug; 66(2):331-6. PubMed ID: 26015278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recurrent atypical hemolytic uremic syndrome after renal transplantation: treatment with eculizumab].
    Latzke AB; Fernández P; Chiurchiu C; Sarmantano D; De Arteaga J; Douthat W; De la Fuente J
    Medicina (B Aires); 2018; 78(2):119-122. PubMed ID: 29659362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.
    Barlas UK; Kıhtır HS; Goknar N; Ersoy M; Akcay N; Sevketoglu E
    Pediatr Nephrol; 2018 Jun; 33(6):1093-1096. PubMed ID: 29558000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult Post-Kidney Transplant Familial Atypical Hemolytic Uremic Syndrome Successfully Treated With Eculizumab: A Case Report and Literature Review.
    Salameh H; Abu Omar M; Alhariri A; Kisra S; Qasem A; Abdulhak AB
    Am J Ther; 2016; 23(4):e1110-5. PubMed ID: 25486517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.
    Fakhouri F; Hourmant M; Campistol JM; Cataland SR; Espinosa M; Gaber AO; Menne J; Minetti EE; Provôt F; Rondeau E; Ruggenenti P; Weekers LE; Ogawa M; Bedrosian CL; Legendre CM
    Am J Kidney Dis; 2016 Jul; 68(1):84-93. PubMed ID: 27012908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era.
    Avila Bernabeu AI; Cavero Escribano T; Cao Vilarino M
    Nephron; 2020; 144(11):537-549. PubMed ID: 32950988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
    Krishnappa V; Gupta M; Elrifai M; Moftakhar B; Ensley MJ; Vachharajani TJ; Sethi SK; Raina R
    Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Systematic Review.
    Gupta M; Govindappagari S; Burwick RM
    Obstet Gynecol; 2020 Jan; 135(1):46-58. PubMed ID: 31809447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
    Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
    BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
    Sengul Samanci N; Ayer M; Ergen A; Ozturk S
    Transfus Apher Sci; 2015 Jun; 52(3):314-6. PubMed ID: 25634788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An extremely rare splice site mutation in the gene encoding complement factor I in a patient with atypical hemolytic uremic syndrome.
    Ipe TS; Lim J; Reyes MA; Ero M; Leveque C; Lewis B; Kain J
    J Clin Apher; 2017 Dec; 32(6):584-588. PubMed ID: 28455885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM; Arias M; Ariceta G; Blasco M; Espinosa L; Espinosa M; Grinyó JM; Macía M; Mendizábal S; Praga M; Román E; Torra R; Valdés F; Vilalta R; Rodríguez de Córdoba S
    Nefrologia; 2015; 35(5):421-47. PubMed ID: 26456110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.